Implantable biocompatible reactor

US10316284B2 · US · B2

Patent metadata
FieldValue
Publication numberUS-10316284-B2
Application numberUS-201515126236-A
CountryUS
Kind codeB2
Filing dateMar 23, 2015
Priority dateMar 25, 2014
Publication dateJun 11, 2019
Grant dateJun 11, 2019

How to read this patent

A practical reading order for non-experts. Skip the full description unless you need deep technical detail.

  1. Title

    What the patent document calls the invention.

  2. Abstract

    A short plain-language summary of the technical disclosure.

  3. Assignees and inventors

    Who owns or filed the patent and who is credited as inventor.

  4. Key dates

    Filing, priority, publication, and grant dates set the timeline.

  5. First independent claim

    The legal scope of protection — read this for what is actually claimed.

  6. CPC / IPC classifications

    Technology tags used to group this patent with similar filings.

  7. Citations and related patents

    Prior art links and similar publications in this corpus.

Abstract

Official abstract text for this publication.

The invention concerns a bioreactor obtained by compressing a mixture of an enzyme, a conductor and chitosan. The conductor can consist of carbon nanotubes. This bioreactor can be produced according to the following steps: preparing a mixture of powders in which the proportion of enzyme powder relative to a carbon nanotube powder is of the order of 50/50 by weight; preparing a viscous solution of chitosan in a ratio of 5 to 15 (in mg) of chitosan to 0.75 to 1.25 (in ml) of acetic acid diluted to 0.4 to 0.6% by volume in water; adding the viscous chitosan to the mixture of powders in a proportion be weight of 3 to 5 of powder to 5 to 10 of chitosan; carrying out a first compression followed by light grinding; carrying out a second compression to produce a pellet; and drying at ambient temperature.

First claim

Opening claim text (preview).

The invention claimed is: 1. A bioreactor obtained by a method comprising the steps of: preparing a mixture of an enzyme powder and a carbon nanotube powder where the proportion of enzyme powder relative to carbon nanotube powder is of the order of 50/50 by weight; preparing a viscous solution of chitosan in a ratio of 5 to 15 (in mg) of chitosan to 0.75 to 1.25 (in ml) of acetic acid diluted to 0.4 to 0.6% by volume in water; adding the viscous chitosan to the mixture of enzyme powder and carbon nanotube powder in a proportion by weight of 3 to 5 of this mixture to 5 to 10 of chitosan; carrying out a first compression followed by light grinding; carrying out a second compression to produce a pellet; and drying at ambient temperature. 2. The bioreactor of claim 1 , wherein the pressure applied during the first and the second compression is within a range from 2,000 to 6,000 kPa. 3. The bioreactor of claim 1 , wherein the solution comprises from 0.002 to 0.005% in mass per volume of genipin. 4. The bioreactor of claim 1 , wherein the solution comprises from 0.001 to 0.005% in mass per volume of caffeic acid. 5. The bioreactor of claim 1 , wherein a porous chitosan-based membrane is laid on an active surface of the bioreactor and bonded at the periphery thereof. 6. The bioreactor of claim 5 , wherein the porous chitosan-based membrane is obtained by a method comprising the steps of: preparing a solution in a ratio of 5 to 15 (in mg) of chitosan to 0.75 to 1.25 (in ml) of acetic acid diluted to 0.4 to 0.6% in water; stirring; pouring on a smooth support; and drying for a period from 2 to 4 days at ambient temperature. 7. The bioreactor of claim 5 , having a pellet-shaped bioelectrode, wherein a conductor is glued by means of conductive glue to the surface of the pellet-shaped bioelectrode opposite to the active surface. 8. The bioreactor of claim 5 , wherein the membrane comprises a plurality of pores having an average diameter in the range from 1 to 10 nanometers. 9. The bioreactor of claim 5 , wherein the membrane comprises a smooth surface facing the pellet-shaped electrode and a rough surface facing outwards. 10. The bioreactor of claim 7 , wherein the membrane comprises a plurality of pores having an average diameter in the range from 1 to 10 nanometers. 11. The bioreactor of claim 7 , wherein the membrane comprises a smooth surface facing the pellet-shaped electrode and a rough surface facing outwards. 12. The bioreactor of claim 2 , wherein the solution comprises from 0.002 to 0.005% in mass per volume of genipin. 13. The bioreactor of claim 2 , wherein the solution comprises from 0.001 to 0.005% in mass per volume of caffeic acid.

Assignees

Inventors

Classifications

  • Pressing, rolling, calendering (membrane electrode assemblies H01M8/1004) · CPC title

  • Fuel cells in portable systems, e.g. mobile phone, laptop · CPC title

  • Amperometric enzyme electrodes for analytes in body fluids, e.g. glucose in blood (amperometry per se G01N27/49; aspects concerning the enzyme reagent C12Q1/001) · CPC title

  • Electrical apparatus, e.g. sparking plugs or parts thereof · CPC title

  • Organic or organo-metallic compounds · CPC title

Patent family

Related publications grouped by family.

External sources

Frequently asked questions

Answers are generated from the same data shown on this page.

What does patent US10316284B2 cover?
The invention concerns a bioreactor obtained by compressing a mixture of an enzyme, a conductor and chitosan. The conductor can consist of carbon nanotubes. This bioreactor can be produced according to the following steps: preparing a mixture of powders in which the proportion of enzyme powder relative to a carbon nanotube powder is of the order of 50/50 by weight; preparing a viscous solution …
Who is the assignee on this patent?
Univ Grenoble Alpes
What technology area does this patent fall under?
Primary CPC classification H01M4/8605. Mapped technology areas include Electricity.
When was this patent published?
Publication date Tue Jun 11 2019 00:00:00 GMT+0000 (Coordinated Universal Time) (B2). Legal status and post-grant events are not shown on this page.
What related patents are in patentsdb?
We list 2 related publications on this page (citations in our corpus or others sharing the same primary CPC).